NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed) (PAR-24-135)

Sponsor: National Institute on Aging

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional) (RFA-MH-25-170)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $3M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards, each year, contingent upon annual appropriations. Application budgets are limited to $300,000 in direct costs in any project year.

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) (RFA-MH-25-171)

Sponsor: National Institutes of Health

Award: NIH BRAIN and partner components intend to commit an estimated total of $2M in fiscal years 2025, 2026, 2027 to fund up to 8 new awards each year for this RFA, contingent upon annual appropriations. The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.

Due Date: Multiple due dates; see announcement.

NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed) (RFA-NS-24-030)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Glenn Foundation for Medical Research Postdoctoral Fellowships in Aging Research

Sponsor: Glenn Foundation for Medical Research(“GFMR”), in partnership with the American Federation for Aging Research (AFAR)

Award: Ten awards of $75,000

Due Date: Deadline for Letters of Intent: January 25, 2024

Notice of Intent to Publish an FOA for Open Measurement Coordinating Network for Non-Pharmacological AD and ADRD Primary Prevention Trials (U24 Clinical Trial Not Allowed) (NOT-AG-23-061)

Sponsor: National Institute on Aging

Due Date: Estimated Publication Date of Notice of Funding Opportunity: February 01, 2024. First Estimated Application Due Date: June 07, 2024.

Notice of Special Interest: Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (NOT-AA-23-020)

Sponsor: National Institutes of Health

Due Date: Applications are accepted on a continuing basis throughout the year up until November 30, 2026.

Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed) (RFA-EB-23-006)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Due Date: Multiple due dates; see announcement.

BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) (RFA-EY-23-001)

Sponsor: National Institutes of Health

Award: Application budgets may not exceed $400,000 total direct costs over a maximum three-year funding period. No more than $200,000 in direct costs may be requested in any single year.

Due Date: Multiple due dates; see announcement.

Chimeric Antigen Receptor (CAR) Approaches to AD/ADRD (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-046)

Sponsor: National Institute on Aging

Due Date: February 07, 2024

Building Neuroscience Research Infrastructure for Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) in Africa (UG3/UH3 Clinical Trial Not Allowed) • (RFA-AG-24-027)

Sponsor: National Institute on Aging

Due Date: February 14, 2024

Notice of Participation of NIA in PAR-23-220, "SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)" (NOT-AG-23-048)

Sponsor: National Institute on Aging

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required) (PAR-23-220)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Health Equity and the Cost of Novel Treatments for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed) (RFA-AG-24-050)

Sponsor: National Institute on Aging

Due Date: LOI due September 29, 2023. Application due October 31, 2023.

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed) (PAR-23-219)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.